Company Profiles

driven by the PitchBook Platform

NKT Therapeutics

Description

Developer of therapeutics based on immune cells called natural killer T (NKT) cells. The company develops therapeutics targeting NKT cells to treat sickle cell disease, autoimmune and inflammatory diseases, cancer and asthma.

2008

Founded

PRIVATE

Status

1-10

Employees

Later Stage VC

Latest Deal Type

$27.5M

Total Amount Raised

4

Investors

Description

Developer of therapeutics based on immune cells called natural killer T (NKT) cells. The company develops therapeutics targeting NKT cells to treat sickle cell disease, autoimmune and inflammatory diseases, cancer and asthma.

Website:

www.nktrx.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Primary Office

880 Winter Street Suite 350 Waltham, MA 02451United States +1 (781) 684-0290
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore NKT Therapeutics's full profile, request a free trial.

NKT Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

NKT Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

NKT Therapeutics Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
CerteonCorporationMinority000 0000000 0000
MedImmune VenturesCorporate Venture CapitalMinority000 0000000 0000
Partners HealthCare InnovationCorporate Venture CapitalMinority000 0000000 0000
SV Health InvestorsVenture CapitalMinority000 0000000 0000
Certeon Corporation
MedImmune Ventures Corporate Venture Capital
Partners HealthCare Innovation Corporate Venture Capital
SV Health Investors Venture Capital

NKT Therapeutics Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Robert Mashal MDPresident, Chief Executive Officer & Board Member
Robert SchaubChief Scientific Officer
Brian Wilson MDCo-Founder & Member of Scientific Advisory Board
Ronald GolsdsteinVice President, Finance
Alem Truneh Ph.DCo-Founder & SAB Member
Robert Mashal MD President, Chief Executive Officer & Board Member
Robert Schaub Chief Scientific Officer
Brian Wilson MD Co-Founder & Member of Scientific Advisory Board
Ronald Golsdstein Vice President, Finance
Alem Truneh Ph.D Co-Founder & SAB Member

NKT Therapeutics Board Members (9)

NameRepresentingRoleSinceContact
Info
Daniel PetreeSelfBoard Member000 0000
David Hung MDSelfBoard Member000 0000
Edward Mascioli MDSV Health InvestorsVenture Partner000 0000
Maggie LeFlore Ph.DMedImmune VenturesBoard Member000 0000
Michael Ross Ph.DSV Health InvestorsManaging Partner, Biotechnology000 0000
Daniel Petree Board Member Self
David Hung MD Board Member Self
Edward Mascioli MD Venture Partner SV Health Investors
Maggie LeFlore Ph.D Board Member MedImmune Ventures
Michael Ross Ph.D Managing Partner, Biotechnology SV Health Investors
Request full access to PitchBook